Data / Form D filings / CORCEPT THERAPEUTICS INC
CORCEPT THERAPEUTICS INC: Form D filings
CORCEPT THERAPEUTICS INC, a pharmaceuticals company in Menlo Park, CA, filed 3 Form D notices with the SEC between 2009 and 2012. The latest, on April 10, 2012, reports $525,305 sold of a $17.5 million offering to 44 investors.
Find out what CORCEPT THERAPEUTICS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 149 Commonwealth Drive, Menlo Park, CA, 94025
- Phone
- (650) 327-3270
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1088856
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 10, 2012 | New notice | $17,545,200 | $525,305 | $17,019,895 | 44 | Mar 25, 2012 | sec.gov |
| Apr 30, 2010 | New notice | $20,338,944 | $7,651,215 | $12,687,729 | 41 | Apr 21, 2010 | sec.gov |
| Oct 30, 2009 | New notice | $18,012,959 | $18,012,959 | $0 | 43 | Oct 16, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| G. Leonard Baker, Jr. | Director | |
| David G. Mahoney | Director | |
| Joseph C. Cook, Jr. | Director | |
| Robert L. Roe, M.D. | Executive Officer | |
| Patrick G. Enright | Director | |
| Charles L. Robb | Executive Officer | |
| Joseph K. Belanoff, M.D. | Executive Officer, Director | |
| Anne M. LeDoux | Executive Officer | |
| James N. Wilson | Director | |
| Steven M. Lo | Executive Officer | |
| Joseph L. Turner | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Apr 9, 2012 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what CORCEPT THERAPEUTICS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.